| 利用者成果(英) |
|
19924
Yoo HB, Moon JW, Kim HR, Lee HS, Miyabayashi K, Park CH, Ge S, Zhang A, Tae YK, Sub Y, Park HW, Gee HY, Notta F, Tuveson DA, Bang S, Kim MY, Roe JS.
A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer
Gastroenterology
2023
165(1):133-148.e17
PubMed ID: 36907523
DOI: 10.1053/j.gastro.2023.02.049
|
|
19984
Groothuis PG, Jacobs DCH, Hermens IAT, Damming D, Berentsen K, Mattaar-Hepp E, Stokman MEM, Boekel TV, Rouwette M, van der Vleuten MAJ, Sesink A, Dijcks FA, Coumans RGE, Schouten J, Glaudemans DH, Wijk DV, Blomenröhr M, Kappers WA, Ubink R, van der Lee MMC, Dokter WHA.
Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody-Drug Conjugate
Mol Cancer Ther
2023
22(6):765-777
PubMed ID: 37042205
DOI: 10.1158/1535-7163.MCT-22-0596
|
|
21084
Kano MT, Kokuryo T, Baba T, Yamazaki K, Yamaguchi J, Sunagawa M, Ogura A, Watanabe N, Onoe S, Miyata K, Mizuno T, Uehara K, Igami T, Yokoyama Y, Ebata T, Nagino M.
Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer.
Anticancer Res
2023
43(3):1009-1016
PubMed ID: 36854520
DOI: 10.21873/anticanres.16245
|
|
21323
Harada Y, Mizote Y, Suzuki T, Hirayama A, Ikeda S, Nishida M, Hiratsuka T, Ueda A, Imagawa Y, Maeda K, Ohkawa Y, Murai J, Freeze HH, Miyoshi E, Higashiyama S, Udono H, Dohmae N, Tahara H, Taniguchi N.
Metabolic clogging of mannose triggers dNTP loss and genomic instability in human cancer cells.
Elife
2023
12
PubMed ID: 37461317
DOI: 10.7554/eLife.83870
|
|
18221
Shichi Y, Gomi F, Sasaki N, Nonaka K, Arai T, Ishiwata T.
Epithelial and Mesenchymal Features of Pancreatic Ductal Adenocarcinoma Cell Lines in Two- and Three-Dimensional Cultures
J Pers Med
2022
12(5):746
PubMed ID: 35629168
DOI: 10.3390/jpm12050746
|
|
20773
Han JH, Kim YK, Kim H, Lee J, Oh MJ, Kim SB, Kim M, Kim KH, Yoon HJ, Lee MS, Minna JD, White MA, Kim HS.
Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells.
Cancer Commun (Lond)
2022
PubMed ID: 35838183
DOI: 10.1002/cac2.12332
|
|
21862
Parisotto M, Vuong-Robillard N, Kalegari P, Meharwade T, Joumier L, Igelmann S, Bourdeau V, Rowell MC, Pollak M, Malleshaiah M, Schmitzer A, Ferbeyre G.
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
Cancers (Basel)
2022
14(22):5597
PubMed ID: 36428689
DOI: 10.3390/cancers14225597
|
|
18216
Kalev P, Hyer ML, Gross S, Konteatis Z, Chen CC, Fletcher M, Lein M, Aguado-Fraile E, Frank V, Barnett A, Mandley E, Goldford J, Chen Y, Sellers K, Hayes S, Lizotte K, Quang P, Tuncay Y, Clasquin M, Peters R, Weier J, Simone E, Murtie J, Liu W, Nagaraja R, Dang L, Sui Z, Biller SA, Travins J, Marks KM, Marjon K.
MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage
Cancer Cell
2021
39(2):209-224.e11
PubMed ID: 33450196
DOI: 10.1016/j.ccell.2020.12.010
|
|
20090
Minami F, Sasaki N, Shichi Y, Gomi F, Michishita M, Ohkusu-Tsukada K, Toyoda M, Takahashi K, Ishiwata T.
Morphofunctional analysis of human pancreatic cancer cell lines in 2- and 3-dimensional cultures.
Sci Rep
2021
11(1):6775
PubMed ID: 33762591
DOI: 10.1038/s41598-021-86028-1
|
|
20100
Xiong W, Friese-Hamim M, Johne A, Stroh C, Klevesath M, Falchook GS, Hong DS, Girard P, El Bawab S.
Translational Pharmacokinetic-pharmacodynamic Modelling of Preclinical and Clinical Data of the Oral MET Inhibitor Tepotinib to Determine the Recommended Phase II Dose.
CPT Pharmacometrics Syst Pharmacol
2021
PubMed ID: 33818908
DOI: 10.1002/psp4.12602
|
|
20106
Neijssen J, Cardoso RMF, Chevalier KM, Wiegman L, Valerius T, Anderson GM, Moores SL, Schuurman J, Parren PWHI, Strohl WR, Chiu ML.
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET.
J Biol Chem
2021
100641
PubMed ID: 33839159
DOI: 10.1016/j.jbc.2021.100641
|
|
20189
Suzuki M, Anko M, Ohara M, Matsumoto KI, Hasegawa S.
Radiation-Induced Autophagy in Human Pancreatic Cancer Cells is Critically Dependent on G2 Checkpoint Activation: A Mechanism of Radioresistance in Pancreatic Cancer.
Int J Radiat Oncol Biol Phys
2021
PubMed ID: 34112559
DOI: 10.1016/j.ijrobp.2021.04.001
|
|
16211
Shyla Gopalakrishnan, Soumya Krishnan Uma, Gayathri Mohan, Amrutha Mohan, Geetha Shanmugam, Vineeth T. V. Kumar, Sreekumar J, Sivakumar K. Chandrika, Dileep Vasudevan, Sai Ravi Chandra Nori, Shijulal Nelson Sathi, Sanil George, Tessy Thomas Maliekal
SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells
Front Immunol
2021
12:740620
PubMed ID: 34867962
DOI: 10.3389/fimmu.2021.740620
|
|
13240
Onodera T, Momose I, Adachi H, Yamazaki Y, Sawa R, Ohba SI, Kawada M.
Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition.
J Biol Chem
2020
PubMed ID: 32978257
DOI: 10.1074/jbc.RA120.013893
|
|
13287
Sasaki N, Gomi F, Yoshimura H, Yamamoto M, Matsuda Y, Michishita M, Hatakeyama H, Kawano Y, Toyoda M, Korc M, Ishiwata T.
FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer.
Cancers (Basel)
2020
PubMed ID: 33066597
DOI: 10.3390/cancers12102976
|
|
13385
Neggers JE, Paolella BR, Asfaw A, Rothberg MV, Skipper TA, Yang A, Kalekar RL, Krill-Burger JM, Dharia NV, Kugener G, Kalfon J, Yuan C, Dumont N, Gonzalez A, Abdusamad M, Li YY, Spurr LF, Wu WW, Durbin AD, Wolpin BM, Piccioni F, Root DE, Boehm JS, Cherniack AD, Tsherniak A, Hong AL, Hahn WC, Stegmaier K, Golub TR, Vazquez F, Aguirre AJ.
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q.
Cell Rep
2020
PubMed ID: 33326793
DOI: 10.1016/j.celrep.2020.108493
|
|
13559
Hu S, Chen X, Xu X, Zheng C, Huang W, Zhou Y, Akuetteh PDP, Yang H, Shi K, Chen B, Zhang Q.
STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation
Front Oncol
2020
10:594224
PubMed ID: 33134183
DOI: 10.3389/fonc.2020.594224
|
|
14279
Falchook GS, Kurzrock R, Amin HM, Xiong W, Fu S, Piha-Paul SA, Janku F, Eskandari G, Catenacci DV, Klevesath M, Bruns R, Stammberger U, Johne A, Bladt F, Friese-Hamim M, Girard P, El Bawab S, Hong DS.
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors
Clin Cancer Res
2020
26(6):1237-1246
PubMed ID: 31822497
DOI: 10.1158/1078-0432.CCR-19-2860
|
|
14280
Hobbs GA, Baker NM, Miermont AM, Thurman RD, Pierobon M, Tran TH, Anderson AO, Waters AM, Diehl JN, Papke B, Hodge RG, Klomp JE, Goodwin CM, DeLiberty JM, Wang J, Ng RWS, Gautam P, Bryant KL, Esposito D, Campbell SL, Petricoin EF 3rd, Simanshu DK, Aguirre AJ, Wolpin BM, Wennerberg K, Rudloff U, Cox AD, Der CJ.
Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
Cancer Discov
2020
10(1):104-123
PubMed ID: 31649109
DOI: 10.1158/2159-8290.CD-19-1006
|
|
14799
Zenke FT, Zimmermann A, Sirrenberg C, Dahmen H, Kirkin V, Pehl U, Grombacher T, Wilm C, Fuchss T, Amendt C, Vassilev LT, Blaukat A.
Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models
Mol Cancer Ther
2020
19(5):1091-1101.
PubMed ID: 32220971
DOI: 10.1158/1535-7163.MCT-19-0734
|
|
15112
Wang Z, Hausmann S, Lyu R, Li TM, Lofgren SM, Flores NM, Fuentes ME, Caporicci M, Yang Z, Meiners MJ, Cheek MA, Howard SA, Zhang L, Elias JE, Kim MP, Maitra A, Wang H, Bassik MC, Keogh MC, Sage J, Gozani O, Mazur PK.
SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy
Cancer Cell
2020
37(6):834-849.e13
PubMed ID: 32442403
DOI: 10.1016/j.ccell.2020.04.014
|
|
11511
Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature
2019
PubMed ID: 30971826
DOI: 10.1038/s41586-019-1103-9
|
|
11811
Mohammad GH, Vassileva V, Acedo P, Olde Damink SWM, Malago M, Dhar DK, Pereira SP.
Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer.
Cancers (Basel)
2019
11(9):1372
PubMed ID: 31527446
DOI: 10.3390/cancers11091372
|
|
11831
Sulahian R, Kwon JJ, Walsh KH, Pailler E, Bosse TL, Thaker M, Almanza D, Dempster JM, Pan J, Piccioni F, Dumont N, Gonzalez A, Rennhack J, Nabet B, Bachman JA, Goodale A, Lee Y, Bagul M, Liao R, Navarro A, Yuan TL, Ng RWS, Raghavan S, Gray NS, Tsherniak A, Vazquez F, Root DE, Firestone AJ, Settleman J, Hahn WC, Aguirre AJ.
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.
Cell Rep
2019
PubMed ID: 31577942
DOI: 10.1016/j.celrep.2019.08.090
|
|
14265
Camblin AJ, Pace EA, Adams S, Curley MD, Rimkunas V, Nie L, Tan G, Bloom T, Iadevaia S, Baum J, Minx C, Czibere A, Louis CU, Drummond DC, Nielsen UB, Schoeberl B, Pipas JM, Straubinger RM, Askoxylakis V, Lugovskoy AA.
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer
Clin Cancer Res
2018
24(12):2873-288
PubMed ID: 29549161
DOI: 10.1158/1078-0432.CCR-17-2262
|
|
14550
Gonzalez PS, O'Prey J, Cardaci S, Barthet VJA, Sakamaki JI, Beaumatin F, Roseweir A, Gay DM, Mackay G, Malviya G, Kania E, Ritchie S, Baudot AD, Zunino B, Mrowinska A, Nixon C, Ennis D, Hoyle A, Millan D, McNeish IA, Sansom OJ, Edwards J, Ryan KM.
Mannose impairs tumour growth and enhances chemotherapy
Nature
2018
563(7733):719-723
PubMed ID: 30464341
DOI: 10.1038/s41586-018-0729-3
|
|
10049
Wong M, Funasaka K, Obayashi T, Miyahara R, Hirooka Y, Hamaguchi M, Goto H, Senga T.
AMPD3 is associated with the malignant characteristics of gastrointestinal stromal tumors.
Oncol Lett
2017
13:1281-1287
PubMed ID: 28454247
DOI: 10.3892/ol.2016.5532
|
|
10120
Murata Y, Kokuryo T, Yokoyama Y, Yamaguchi J, Miwa T, Shibuya M, Yamamoto Y, Nagino M.
The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer.
Anticancer Res.
2017
37:589-598
PubMed ID: 28179305
DOI: 10.21873/anticanres.11352
|
|
10220
Kania E, Pająk B, O'Prey J, Sierra Gonzalez P, Litwiniuk A, Urbańska K, Ryan KM, Orzechowski A.
Verapamil treatment induces cytoprotective autophagy by modulating cellular metabolism.
FEBS J.
2017
284:1370-1387
PubMed ID: 28342290
DOI: 10.1111/febs.14064
|
|
11016
Population Pharmacokinetics of Liposomal Irinotecan
CLINICAL PHARMACOLOGY & THERAPEUTICS
2017
102
PubMed ID: 28445610
DOI: 10.1002/cpt.720
|
|
14239
Wang J, Anderson MG, Oleksijew A, Vaidya KS, Boghaert ER, Tucker L, Zhang Q, Han EK, Palma JP, Naumovski L, Reilly EB.
ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both MET-Amplified and c-Met-Overexpressing Tumors, Irrespective of MET Pathway Dependence
Clin Cancer Res
2017
23(4):992-1000
PubMed ID: 27573171
DOI: 10.1158/1078-0432.CCR-16-1568
|
|
14741
Sakamaki JI, Wilkinson S, Hahn M, Tasdemir N, O'Prey J, Clark W, Hedley A, Nixon C, Long JS, New M, Van Acker T, Tooze SA, Lowe SW, Dikic I, Ryan KM.
Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function
Mol Cell
2017
66(4):517-532
PubMed ID: 28525743
DOI: 10.1016/j.molcel.2017.04.027
|
|
14760
Kim JW, Abudayyeh OO, Yeerna H, Yeang CH, Stewart M, Jenkins RW, Kitajima S, Konieczkowski DJ, Medetgul-Ernar K, Cavazos T, Mah C, Ting S, Van Allen EM, Cohen O, Mcdermott J, Damato E, Aguirre AJ, Liang J, Liberzon A, Alexe G, Doench J, Ghandi M, Vazquez F, Weir BA, Tsherniak A, Subramanian A, Meneses-Cime K, Park J, Clemons P, Garraway LA, Thomas D, Boehm JS, Barbie DA, Hahn WC, Mesirov JP, Tamayo P.
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States
Cell Syst
2017
5(2):105-118
PubMed ID: 28837809
DOI: 10.1016/j.cels.2017.08.002
|
|
7191
Kawakubo K, Ohnishi S, Hatanaka Y, Hatanaka KC, Hosono H, Kubota Y, Kamiya M, Kuwatani M, Kawakami H, Urano Y, Sakamoto N.
Feasibility of Using an Enzymatically Activatable Fluorescence Probe for the Rapid Evaluation of Pancreatic Tissue Obtained Using Endoscopic Ultrasound-Guided Fine Needle Aspiration: a Pilot Study.
Mol Imaging Biol
2016
18:463-71
PubMed ID: 26431952
DOI: 10.1007/s11307-015-0898-5
|
|
9663
Tarhan YE, Kato T, Jang M, Haga Y, Ueda K, Nakamura Y, Park JH.
Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
Neoplasia
2016
18:265-272
PubMed ID: 27237318
DOI: 10.1016/j.neo.2016.03.005
|
|
9977
Sellmann C, Doerner A, Knuehl C, Rasche N, Sood V, Krah S, Rhiel L, Messemer A, Wesolowski J, Schuette M, Becker S, Toleikis L, Kolmar H, Hock B.
Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates.
J. Biol. Chem.
2016
291:25106-25119
PubMed ID: 27694443
DOI: 10.1074/jbc.M116.753491
|
|
12674
Kokuryo T, Hibino S, Suzuki K, Watanabe K, Yokoyama Y, Nagino M, Senga T, Hamaguchi M.
Nek2 siRNA therapy using a portal venous port-catheter system for liver metastasis in pancreatic cancer
Cancer Sci
2016
107(9):1315-20
PubMed ID: 27316377
DOI: 10.1111/cas.12993
|
|
14130
Marjon K, Cameron MJ, Quang P, Clasquin MF, Mandley E, Kunii K, McVay M, Choe S, Kernytsky A, Gross S, Konteatis Z, Murtie J, Blake ML, Travins J, Dorsch M, Biller SA, Marks KM.
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Cell Rep
2016
15(3):574-587
PubMed ID: 27068473
DOI: 10.1016/j.celrep.2016.03.043
|
|
7372
Miwa T, Kokuryo T, Yokoyama Y, Yamaguchi J, Nagino M.
Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer.
Cancer Med
2015
4:1091-100
PubMed ID: 25914189
DOI: 10.1002/cam4.453
|
|
15118
Sano Y, Hashimoto E, Nakatani N, Abe M, Satoh Y, Sakata K, Fujii T, Fujimoto-Ouchi K, Sugimoto M, Nagahashi S, Aoki M, Motegi H, Sasaki E, Yatabe Y.
Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression
Mol Cancer Ther
2015
14(2):533-41
PubMed ID: 25522765
DOI: 10.1158/1535-7163.MCT-14-0456
|
|
5018
Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.
Frizzled-2: A potential novel target for molecular pancreatic cancer therapy.
Oncol Lett
2014
7(1):74-78
PubMed ID: 24348824
DOI: 10.3892/ol.2013.1681
|
|
18682
Yan SB, Peek VL, Ajamie R, Buchanan SG, Graff JR, Heidler SA, Hui YH, Huss KL, Konicek BW, Manro JR, Shih C, Stewart JA, Stewart TR, Stout SL, Uhlik MT, Um SL, Wang Y, Wu W, Yan L, Yang WJ, Zhong B, Walgren RA.
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
Invest New Drugs
2013
31(4):833-44
PubMed ID: 23275061
DOI: 10.1007/s10637-012-9912-9
|
|
5843
Bladt F, Faden B, Friese-Hamim M, Knuehl C, Wilm C, Fittschen C, Grädler U, Meyring M, Dorsch D, Jaehrling F, Pehl U, Stieber F, Schadt O, Blaukat A.
EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors.
Clin Cancer Res
2013
19(11):2941-51
PubMed ID: 23553846
DOI: 10.1158/1078-0432.CCR-12-3247
|
|
9175
Dan Cojocari, Ravi N Vellanki, Brandon Sit, David Uehling, Marianne Koritzinsky, Bradly G Wouters
New Small Molecule Inhibitors of UPR Activation Demonstrate That PERK, but Not IRE1α Signaling Is Essential for Promoting Adaptation and Survival to Hypoxia
Radiother Oncol
2013
108 (3), 541-7
PubMed ID: 23830192
DOI: 10.1016/j.radonc.2013.06.005
|
|
12868
Yoshida M, Takimoto R, Murase K, Sato Y, Hirakawa M, Tamura F, Sato T, Iyama S, Osuga T, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J.
Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach
PLoS One
2012
7(7):e39545
PubMed ID: 22808043
DOI: 10.1371/journal.pone.0039545
|
|
7696
Seki T, Kokuryo T, Yokoyama Y, Suzuki H, Itatsu K, Nakagawa A, Mizutani T, Miyake T, Uno M, Yamauchi K, Nagino M.
Antitumor effects of α-bisabolol against pancreatic cancer.
Cancer Sci.
2011
102:2199-205
PubMed ID: 21883695
DOI: 10.1111/j.1349-7006.2011.02082.x
|
|
5022
Mitsuno M, Kitajima Y, Ohtaka K, Kai K, Hashiguchi K, Nakamura J, Hiraki M, Noshiro H, Miyazaki K.
Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1.
Int J Oncol
2010
36(2):341-9
PubMed ID: 20043067
|
|
5875
Mishra R, Miyamoto M, Yoshioka T, Ishikawa K, Matsumura Y, Shoji Y, Ichinokawa K, Itoh T, Shichinohe T, Hirano S, Kondo S.
Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
Int J Oncol
2009
34(5):1231-40
PubMed ID: 19360336
|
|
8748
Jin H, Yang R, Zheng Z, Romero M, Ross J, Bou-Reslan H, Carano RA, Kasman I, Mai E, Young J, Zha J, Zhang Z, Ross S, Schwall R, Colbern G, Merchant M.
MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival.
Cancer Res.
2008
68:4360-8
PubMed ID: 18519697
DOI: 10.1158/0008-5472.CAN-07-5960
|
|
19087
Suzuki T, Lu J, Zahed M, Kita K, Suzuki N.
Reduction of GRP78 expression with siRNA activates unfolded protein response leading to apoptosis in HeLa cells
Arch Biochem Biophys
2007
468(1):1-14
PubMed ID: 17936241
DOI: 10.1016/j.abb.2007.09.004
|
|
3106
Takeda, Ami, Osaki, Mitsuhiko, Adachi, Keiko, Honjo, Soichiro, Ito, Hisao
Role of the phosphatidylinositol 3'-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines.
Pancreas
2004
28:353-8
PubMed ID: 15084985
DOI: 10.1097/00006676-200404000-00026
|
|
19026
Hirai F, Motoori S, Kakinuma S, Tomita K, Indo HP, Kato H, Yamaguchi T, Yen HC, St Clair DK, Nagano T, Ozawa T, Saisho H, Majima HJ.
Mitochondrial signal lacking manganese superoxide dismutase failed to prevent cell death by reoxygenation following hypoxia in a human pancreatic cancer cell line, KP4
Antioxid Redox Signal
2004
6(3):523-35
PubMed ID: 15130279
DOI: 10.1089/152308604773934288
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
